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Abstract
Background: The inflammatory nature of falciparum malaria has been acknowledged since
increased circulating levels of tumour necrosis factor (TNF) were first measured, but precisely
where the mediators downstream from this prototype inflammatory mediator are generated has
not been investigated. Here we report on the cellular distribution, by immunohistochemistry, of
migration inhibitory factor (MIF) and inducible nitric oxide synthase (iNOS) in this disease, and in
sepsis.
Methods: We stained for MIF and iNOS in tissues collected during 44 paediatric autopsies in
Blantyre, Malawi. These comprised 42 acutely ill comatose patients, 32 of whom were diagnosed
clinically as cerebral malaria and the other 10 as non-malarial diseases. Another 2 were non-
malarial, non-comatose deaths. Other control tissues were from Australian adults.
Results: Of the 32 clinically diagnosed cerebral malaria cases, 11 had negligible histological change
in the brain, and no or scanty intravascular sequestration of parasitised erythrocytes, another 7 had
no histological changes in the brain, but sequestered parasitised erythrocytes were present (usually
dense), and the remaining 14 brains showed micro-haemorrhages and intravascular mononuclear
cell accumulations, plus sequestered parasitised erythrocytes. The vascular walls of the latter group
stained most strongly for iNOS. Vascular wall iNOS staining was usually of low intensity in the
second group (7 brains) and was virtually absent from the cerebral vascular walls of 8 of the 10
comatose patients without malaria, and also from control brains. The chest wall was chosen as a
typical non-cerebral site encompassing a range of tissues of interest. Here pronounced iNOS
staining in vascular wall and skeletal muscle was present in some 50% of the children in all groups,
including septic meningitis, irrespective of the degree of staining in cerebral vascular walls. Parasites
or malarial pigment were rare to absent in all chest wall sections. While MIF was common in chest
wall vessels, usually in association with iNOS, it was absent in brain vessels.
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Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/6Conclusions: These results agree with the view that clinically diagnosed cerebral malaria in
African children is a collection of overlapping syndromes acting through different organ systems,
with several mechanisms, not necessarily associated with cerebral vascular inflammation and
damage, combining to cause death.
Background
Falciparum malaria is a complex multi-organ disease that
is often fatal. It is not yet clear how Plasmodium falciparum
causes the seizures, coma, cerebral oedema, hypoglycae-
mia and respiratory failure seen in a proportion of infect-
ed African children. Intense sequestration of parasitised
erythrocytes in brain microvessels in fatal malarial coma
was first described over a hundred years ago [1], and the
mechanisms by which this phenomenon might contrib-
ute to coma or death have been the subject of speculation
since then. More recently data have accumulated to sug-
gest that in systemic infections such as malaria, excessive
production of pro-inflammatory cytokines may play an
important role in the generation of symptoms and disease
[2]. Evidence supporting this concept includes the ability
of experimental malaria to prime for tumour necrosis fac-
tor (TNF) production [2], the close similarity to malaria of
the side effects observed when TNF is administered to tu-
mour patients [3], and clinical studies showing a correla-
tion between disease severity and the circulating levels of
TNF in African [4,5] and Melanesian [6] children and Eu-
ropean adults [7]. A large body of experimental and clini-
cal evidence has now accumulated [8] suggesting that
excessive inflammatory cytokine production, and its ensu-
ing consequences, could play a crucial role in the patho-
genesis of severe falciparum malaria. The inability of anti-
TNF antibody to reverse severe malarial disease is some-
times cited against this concept [9], although subsequent-
ly evidence emerged that preliminary administration of
anti-TNF can prevent the characteristic febrile reaction to
treatment in rickettsial infection [10]. This is consistent
with the existing evidence that TNF is an early link in the
chain of events causing acute disease.
The literature on the range of cytokines involved in the
pathogenesis of sepsis is now complex, and has taken
some unexpected turns over recent years, none more so
than the central involvement of migration inhibitory fac-
tor (MIF). This was the first cytokine to be described, and
was so named because of its function in delayed hypersen-
sitivity [11,12]. A decade later MIF was detected, by its
original functional assay, in experimental malaria [13].
MIF is now recognised to potentiate lethal endotoxaemia
through enhancing TNF release [14], to be a pituitary-de-
rived antagonist of glucocorticoids, and to be released
from a wide range of cell types, including macrophages
[15]. Circulating levels of MIF are raised in human sepsis
[16–18], and its importance in this disease state is implied
by the remarkable degree of protection given by MIF-neu-
tralizing antibody in the caecal ligation and puncture
model of sepsis [16]. While MIF can be viewed as a pro-
inflammatory cytokine, it also has properties characteris-
tic of a hormone, and can be regarded as largely acting
through antagonising the ability of glucocorticoids to in-
hibit the generation of pro-inflammatory cytokines [19].
A role for MIF in dyserythropoiesis has been suggested in
a mouse model of malaria [20], and it has been localised
by immunohistochemistry in the human kidney [21] cor-
nea [22], endothelial cell [22], synovium [23] and en-
dometrium.[24]. Since the glucocorticoid-antagonising
activity of MIF [19] implies it is a major enhancer of in-
flammation, and circulating inflammatory mediators are
increased in malaria [4,5], we have investigated, through
immunohistochemistry, its distribution in fatal human
malaria and sepsis. The cellular location of systemic MIF
generation has not been explored in either of these condi-
tions, or any other cause of acute systemic inflammatory
disease.
TNF and other pro-inflammatory cytokines have the ca-
pacity to generate the inducible form of nitric oxide syn-
thase (iNOS), and thus generate a continuous, potentially
large, supply of nitric oxide (NO) in tissues that normally
experience only low, tightly controlled, levels of this ubiq-
uitous cellular messenger. The potential roles for NO in
malaria and other parasitic diseases are many, and have
effects both protective and harmful to the host [25]. It has
been argued, for instance, that excess NO, generated in
critical locations by iNOS, could be functionally impor-
tant in falciparum malaria, accounting for some of the re-
versible cerebral symptoms [26,27] and malarial
tolerance [28], and there is evidence for its involvement in
the immunosuppression [29] and weight loss [30] seen in
experimental malaria. A parallel set of arguments has
been developing for sepsis [31,32]. It is still uncertain
whether overproduction of NO in acute illness helps or
harms the host. Nevertheless, as the signalling roles of NO
are defined better, the possibility that it may contribute to
the pathogenesis of disease is being increasingly
recognised.
In several studies, evidence of increased NO production in
severe malaria has been sought by assaying plasma, urine
or cerebrospinal fluid for nitrites and nitrates, the oxida-
tion products of NO. These data were difficult to interpret,
since the presence of nitrate in a body fluid gives noPage 2 of 17
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Patient no. Age (mo) Sex Parasitae-
mia (Pf) &/or 
Organism 
cultured
Admitting 
coma score
Coma duration 
Before/After 
admission (h)
Brain vessel 
iNOS (n)
Brain vessel 
MIF (n)
Parasites in 
brain 
vessels
Chest Wall 
vessel 
iNOS
Chest Wall 
vessel MIF
Chest Wall 
muscle 
iNOS
4 20 M 18.6% 2 missing/6 0-1+ (6) 0 (3) 1+ 0-1+ 4+ 2+
7 29 F 4+ 0 1/1 0-1+ (6) 0 (3) 1+ 0-1+ 3+ 4+
31 39 M 49% 1 7/22 0-1+ (9) 0 (3) 1+ 0-1+ 3+ 0-1+
33 25 M 0.26% 0 2/15 0-1+ (8) 0 (3) 1+ 2+ 2+ 0-1+
37 6 M 34% ¶ mal. 
trace
2 missing/14 0-1+ (9) 0 (3) 1+ 3+ 3+ 3+
47 22 F 11% 1 6/44 0-1+ (13) 0 (3) 1+ 0-1+ 3+ 0-1+
49 17 M 0.09% 1 2/34 0-1+ (12) 0 (3) 1+ 2+ 3+ 4+
22 18 M 1.75% 0 1/3 2+ (8) 0 (3) 1+ 3+ ND 2+
38 84 F 22% 0 5/35 2+ (9) 0 (3) 1+ 0-1+ 2+ 0-1+
45 34 M 2.5% 0 8/28 2+ (13) 0 (3) 1+ 0-1+ 3+ 0-1+
23 30 F 29% 0 5/7 3+ (9) 0 (3) 1+ 3+ 3+ 0-1+
CM(B), sequestered parasites only
5 14 M 3.5% 1 NA/18 0-1+ (3) 0 (3) 4+ 4+ 3+ 4+
21 25 F 0.33% 2 2/12 0-1+ (3) 0 (3) 4+ 4+ 4+ 4+
16 51 F 5.5% 1 22/6 0-1+ (3) 0 (3) 2+ 2+ 4+ 2+
39 18 M 0.27% 2 6/18 0-1+ (9) 0 (3) 4+ 2+ 3+ 2+
42 37 F 20% 0 missing 0-1+ (11) 0 (3) 4+ 3+ 4+ 2+
25 44 F 0.02% 2 1/11 2+ (8) 0 (3) 4+ 3+ 3+ 0-1+
1 27 F 31.1% 0 7/18 3+ (3) 0 (3) 2+ 2+ ND 2+
CM(C), sequestered parasites plus local intravascular inflammation
13 22 M 36.52% 0-1 15/1 0-1+ (3) 0 (3) 3+ 2+ 2+ 2+
27 20 M 53.4% & Sal. 
typhi-m
0 missing/3 2+ (3) 0 (3) 3+ 4+ 3+ 0-1+
28 61 F 23.6% 0 12/0 2+ (9) 0 (3) 2+ 0-1+ 2+ 0-1+
29 43 M 33% 2 18/11 3+ (9) 0 (3) 3+ 0-1+ 3+ 0-1+
32 18 F 47% 0 24/3 3+ (9) 0 (3) 3+ 0-1+ 4+ 0-1+
34 70 M 2.4% 1 36/3 3+ (9) 0 (3) 4+ 3+ 3+ 2+
35 114 M 0.21% 1 12/15 3+ (9) 0 (3) 3+ 2+ 2+ 2+
36 21 F 0.88% 2 3/10 3+ (8) 0 (3) 2+ 3+ 3+ 3+
48 48 M 0.03% 2 4/22 3+ (13) 0 (3) 3+ 2+ 2+ 3+
6 17 F 5.8% 0 19/1 4+ (9) 0 (3) 3+ 4+ 3+ 4+
9 16 M 0.03% 1 11/23 4+ (3) 0 (3) 3+ 3+ 3+ 4+
11 29 F 29.5% & H. 
influ. B
1 28/30 4+ (3) 0 (3) 2+ 4+ 4+ 4+
15 8 F 0.94% 2 8/15 4+ (3) 0 (3) 2+ 3+ 2+ 3+
26 30 M 19% 1 1/31 4+ (9) 0 (3) 4+ 4+ 4+ missing
COMA (clinically judged not cerebral malaria)
* 8 41 F negative 3 3/9 3+ (3) 0 (3) negative 0-1+ 4+ 0-1+
10 66 F 0.01% 0 5/4 0-1+ (3) 0 (3) negative 2+ 0-1+ 2+
12 6 M Sal. 
enteritidis
2 1/4 0-1+ (3) 0 (3) negative 2+ 4+ 2+
14 9 F E. coli 0 missing 0-1+ (3) 0 (3) negative 4+ 4+ 4+
17 51 F negative 0 2/9 0-1+ (3) 0 (3) negative 0-1+ 0-1+ 0-1+
18 7 F H. influenzae 
B
1 48/14 0-1+ (3) 0 (3) negative 3+ 3+ 4+
20 96 F Tuberculosis 0 missing 0-1+ (3) 0 (3) negative 4+ 2+ 0-1+
24 48 F Strep. pneu-
moniae
3 missing 0-1+ (3) 0 (3) negative 2+ 4+ 2+
40 26 F 0.02% 1 24/63 2+ (9) 0 (3) negative 0-1+ 4+ 2+
44 21 F negligible 1 7/3 0-1+ (13) 0 (3) negative 2+ 2+ 2+
MALAWIAN CONTROLS (without terminal coma)Page 3 of 17
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portant issue when investigating the functional relevance
of a short-lived molecule that can be formed in many tis-
sues, and acts very close to its cell of origin. We have ap-
proached this problem by employing
immunohistochemical staining for iNOS on the same
range of formalin-fixed, wax-embedded tissues collected
at autopsy from cases of falciparum malaria and other
acute systemic diseases, including sepsis, as we stained for
MIF. Several patterns were observed in the brain of chil-
dren. The outcome is consistent with the view that clini-
cally diagnosed cerebral malaria in African children is best
viewed as a collection of overlapping syndromes, with
several mechanisms potentially combining to cause coma
and death.
Methods
Case Tissues
All 44 subjects (26 females) were children who had been
admitted to the Malaria Project wards in the Department
of Paediatrics at the Queen Elizabeth Central Hospital in
Blantyre, Malawi. Ages ranged from 6 months to 12 years
(Table 1). Subjects had been comprehensively evaluated
during life, through clinical history and examination and
by laboratory tests. They were treated as clinically indicat-
ed with intravenous fluids, glucose, antimalarial drugs,
antibiotics, anticonvulsant and antipyretic drugs and
blood transfusion. Thirty-two patients were clinically di-
agnosed as cerebral malaria because they (a) died with
coma (Blantyre coma score 2/5 or less, lasting for at least
2 hours before death), showing no improvement with
50% dextrose or within the first 2 hours of treatment for
seizures, (b) had P. falciparum asexual parasitaemia, and
(c) had no evidence of pyogenic meningitis in the initial
CSF sample and no alternative explanation for coma. An-
other 10 patients were comatose on admission and before
death, had very low or no peripheral malaria parasitae-
mia, and were considered on clinical grounds to be suffer-
ing from a disease other than malaria. The case fatality rate
of children admitted to the ward was 16%. Family mem-
bers were asked for their permission for the autopsy to be
conducted: this request was made by one of the Malawian
physicians who had been involved in the management of
the patient. Autopsies were performed as quickly after
death as possible, with post-mortem intervals ranging
from 2 to 14.5 hr. Tissue samples were placed into 10%
neutral buffered formalin for fixation. The project was ap-
proved by ethics and research boards of Malawi, the Liver-
pool School of Tropical Medicine and the Australian
National University.
Control tissues
Various adult controls from Australian sources were stud-
ied. These comprised sections of 5 blocks of tissue,
trimmed from the periphery of tumour excisions from
adult chest wall, and containing skeletal muscle, adipose
tissue and small blood vessels. Mid-brain sections from 4
adults who had died of coronary artery disease, and from
another 3 who died of non-infectious, non-cerebral con-
ditions (Brain Bank for Sydney Central Area Health Sci-
ence Approval X980216), were also stained. In addition,
tissues from 2 Malawian children who were enrolled in
this study served as local controls, in the sense that no
coma was present at any stage. One of these children grew
Salmonella typhimurium from cerebrospinal fluid and
blood, and died after an acute gastrointestinal haemor-
rhage, and the other grew scanty Streptococcus pneumoniae
from the cerebrospinal fluid.
Immunohistochemistry
Formalin-fixed tissue samples were embedded in paraffin,
sectioned (3–6 microns) on to polylysine-coated slides,
and stained with haematoxylin and eosin (H&E) for rou-
tine morphology. A goat polyclonal antibody against MIF,
raised against an Escherichia. coli-expressed recombinant
human MIF, was purchased from R & D Systems (Cat. No.
AF289-PB). Anti-iNOS antibodies were purchased from
Transduction Laboratories (N32020, a monoclonal di-
rected against bases 772–787 of mouse iNOS), Santa Cruz
(Cat. SC-650, a polyclonal against bases 1126–1144) and
StressGen (Cat. KAP-NO001, a polyclonal against bases
1131–1144). Anti-myoglobin was used as irrelevant pri-
41 29 F Sal. 
typhimurium
5 NA/NA 0-1+ (13) 0 (3) negative 0-1+ 0-1+ 0-1+
* 50 144 F Strep. pneu-
moniae
5 NA/NA 0-1+ (13) 0 (3) negative 0-1+ 3+ 0-1+
AUSTRALIAN CONTROLS
n = 5 F/M NA NA NA/NA NA NA negative 0-1+ 0-1+ 0-1+
n = 7 F/M NA 5 NA/NA 0-1+ (3) 0 (3 ea) negative NA NA NA
* Serologically positive for HIV (n) Number of brains areas examined ND = not done NA = not applicable
Table 1: CM(A), no apparent brain pathology (Continued)Page 4 of 17
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antibody was omitted. The procedure was modified from
Cobbs and co-workers [33]. Antigen retrieval was per-
formed by immersion in 0.01 M citrate buffer, pH 6.0, in
a waterbath at 95°C for 20 min and then cooling to room
temperature while still immersed in buffer. After quench-
ing with 3% H2O2 and treating with primary antibody
(dilution of the stock solution within the range 1:100 to
1:2,500) at room temperature for 1–4 hr, biotin-conjugat-
ed secondary antibody and streptavidin-conjugated horse
radish peroxidase from an LSAB+ kit (DAKO) were ap-
plied to sections for 20 min at room temperature to am-
plify the antigen signal for subsequent 3,3'-
diaminobenzidine (DAB) staining. All three anti-iNOS
antibodies detected the same antigen distribution, al-
though the StressGen polyclonal required a higher con-
centration of protein to stain to the same degree as the
other two antibodies. Across a range of tissues, optimal di-
lutions of the Transduction monoclonal anti-iNOS and
the R&D polyclonal anti-MIF were determined by using
1:100 to 1:10,000 as primary antibodies on control and
case tissues. Known positive controls were stained in each
run, and runs were often duplicated on different days to
confirm repeatability. Sections were counterstained with
haematoxylin, and outcomes with a dilution of 1:2000
(MIF) or 1:1000 (iNOS) are shown to illustrate the ob-
served changes.
Statistical analysis
The differences between the relative densities of iNOS
staining, combining 0/1+ and 2+ as low, and 3+ and 4+ as
high, were compared using Fischer's exact test, on Instat
software. Probability values less than 0.05 were regarded
as significant. For the frequency counts in a 4 × 4 table
classified by MIF score and iNOS score, Cohen's kappa
(pages 395–397) of Bishop [34] was used to test whether
the frequencies on the diagonal were greater than would
be expected by chance. The table was also tested for sym-
metry using G2, the goodness of fit statistic given on p.
283 (reference equation 8-2-1) of Bishop [34].
Histological examination of brain
Depending on availability, sections from 3 to 13 blocks
(see Table 1) of a range of brain regions were examined.
Samples were from frontal lobe, parietal lobe, occipital
calcarine fissure, hippocampus, basal ganglia, thalamus,
mid-brain, pons and cerebellum, with mid-brain and
pons almost always included. All were stained with hema-
toxylin and eosin (H&E). The overall density of parasites
was described as 1 when only widely scattered individual
parasites were present, as 2 when low numbers of para-
sites were seen, but more frequently, as 3 when most ves-
sels contained parasites, and as 4 when exceptional
numbers were present. Scores from cases clinically diag-
nosed as cerebral malaria were confirmed by examining
more blocks, up to 13, with a median of 9, for each case.
The additional blocks came from the medulla, cerebellar
tonsils, cerebellar dentate, spinal cord and choroid plexus.
Histopathological changes in tissue were documented in-
cluding presence of micro-haemorrhages, intravascular
inflammatory infiltrates and fibrin deposition.
Quantification of staining
The degree of staining in tissues was approximately quan-
tified into categories 0-1+, 2+, 3+ and 4+ by evaluating
stain density alone (see Figures), not the proportion of
positively stained cells in a field. Observers (IAC and
MMA) blinded to the clinical diagnoses examined the sec-
tions initially. To further establish objectivity, and to meet
the challenge of a number of collaborators in different
parts of the world being able to access and compare the
same material from so many sets of tissues, the brain and
other sections were comprehensively photographed. An
additional observer (CGH) independently monitored that
the tissue sections were fairly represented by the range of
photographs taken of each. A large number (>1500) of
digital images, graded and in their original groupings,
were distributed on CD-ROM to all members of the inves-
tigating team for independent examination.
Cases were allocated into the categories used in the Re-
sults section purely on clinical and histological grounds.
The 32 patients with clinically diagnosed cerebral malaria
were grouped according to cerebral light microscopic
changes into three categories:
• Category A (n = 11) had no or scanty (score 1) intracer-
ebral parasites and no tissue pathology;
• Category B (n = 7) had sequestered parasites in brain
vessels (score 2, 3 or 4) without tissue pathology;
• Category C (n = 14) had both sequestered parasites
(score 2, 3 or 4) and inflammatory pathology in the form
of intravascular inflammatory infiltrates, fibrin deposi-
tion and/or microhaemorrhages.
Several groups of patients clinically diagnosed as non-ma-
larial illnesses were used as comparison cases:
• Coma of other causes (n = 10). These included patients
presenting in coma but not clinically diagnosed as cere-
bral malaria.
• Non-comatose illness (n = 2).
The individual diagnoses in these patients with non-ma-
larial illnesses are listed in the Table 1.Page 5 of 17
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MIF staining
Tissues exposed to the outside environment
Immunohistochemical evidence of MIF was strongly
present (3+ – 4+) in control tissue from a range of loca-
tions exposed to the outside environment. This included
cells such as keratinocytes of the epidermis and cells form-
ing sebaceous glands and hair follicle sheaths, bronchial
epithelial cells, and alveolar macrophages. The pattern
was the same in these locations for iNOS, and serve as
positive staining controls.
Brain
MIF staining proved to be identical in all brains, and thus
results for this mediator, in contrast to those for iNOS, are
described together. It was amply detectable in inflamed
meninges (not shown), but not in more than occasional
trace amounts in blood vessel walls within the brain pa-
renchyma in any brain, including those from controls. In
contrast, it was present widely and uniformly in astrocytes
(cytoplasm, but not in nuclei), and ependymal cells (cyto-
plasm, and often nuclei), to a degree that did not vary sig-
nificantly between brains. This was true for the total of the
53 human brains of all origins sectioned and stained for
both MIF and iNOS. These comprised 7 from adults who
had died in Australia of non-infectious, non-cerebral con-
ditions (represented by Fig. 1A), the 2 childhood controls
from Malawi (Fig. 1C), 32 cases of cerebral malaria (Fig.
1E), the 10 with non-malarial fever and coma, including
the 5 with culture-positive bacterial septic meningitis (E.
coli illustrated in Fig. 1G). We also examined brains from
17 other children dying of various causes in Malawi and
again found no evidence of MIF in cerebral vascular walls
(data not shown).
Blood vessels in chest wall
MIF staining in chest wall blood vessels (Table 1) was neg-
ligible in sections from Australian control adults (Fig. 1B)
and the non-febrile one of the pair of non-comatose Ma-
lawian control children (Fig. 1D), and was strong (3+ or
4+ on a 0–4 scale) in chest wall vessels from 24 of 31 cer-
ebral malaria patients (Fig. 1F), and 4 of 5 cases of culture-
positive sepsis (S. pneumoniae illustrated in Fig. 1H). Both
cytoplasm and nuclei stained in endothelial cells and
smooth muscle. By Kruskal-Wallis non-parametric ANO-
VA there was no difference in MIF staining in chest wall
blood vessels in the three categories of cerebral malaria.
Skeletal muscle in chest wall
MIF was not detectable in normal skeletal muscle from 2
control Australian adult samples (Fig. 2A), nor samples
from 2 control Malawian children (Fig. 2B), but was
present in the nuclei of skeletal muscle from almost all of
the malaria and culture-positive sepsis cases (12 of 14)
that showed high iNOS (3+ or 4+ on a 0–4 scale) in the
surrounding myofibrils. Staining was rarely present in cy-
toplasm. A representative malaria example is shown in
Fig. 2C, and sepsis (Haemophilus influenzae) in Fig. 2D.
The corresponding iNOS immunostaining is shown in
Figs 4H,4F,4E, and 5D respectively. MIF staining was
largely confined to nuclei, but even with the strongest
staining only some two-thirds of nuclei were positive in
any section.
iNOS staining
Coma with falciparum malaria
Brain blood vessel walls
The 32 cases clinically diagnosed as cerebral malaria were
examined after staining with H&E and anti-iNOS anti-
body. Differences in degree of staining between the vari-
ous parts of the brain in any single individual were slight
to negligible. All iNOS staining was in cytoplasm only. It
was detectable in some glial cells and some motor neu-
rons across the brain, but the strongest staining, and dif-
ferences, were in the walls of small blood vessels, both
smooth muscle and endothelial cells. iNOS staining was
analysed according to histological categories A, B, and C
(see Methods). Category A (11 cases with no discernible
histological changes and only the occasional rare malarial
pigment or parasites within vessels). Seven of these 11
scored nil to trace for vascular wall iNOS (0-1+, see Table
1, and Fig. 3A). Another 3 scored 2+, and one scored 3+.
Category B (seven cases with no histological changes but
with sequestered parasitised erythrocytes). Sequestration
in this group usually consisted of young parasites (tropho-
zoites), and was commonly intense (Fig. 3B). Five of these
7 scored 0-1+ for vascular wall iNOS, one 2+, and one 3+
(Table 1). Category C (14 cases showing micro-haemor-
rhages, intravascular mononuclear cell accumulations,
and also sequestered parasites). iNOS staining was strong-
er in this group, with one case scoring 0-1+, 2 scoring 2+,
6 scoring 3+, and 5 scoring 4+ (Table 1, and Fig. 3C).
iNOS staining was conspicuously concentrated in areas of
microhaemorrhage. iNOS staining in vessel walls in Cate-
gory C was significantly more likely to be scored as 3+ or
4+ than in Categories A and B combined (p = 0.0005),
and when compared to A (p = 0.002) or B (p = 0.015) sep-
arately. Immunostaining in Categories A and B were not
significantly different (p = 1.000).
Where mononuclear cellular accumulations were present
they stained in parallel with the vessel walls (Fig. 3D). The
strongest (4+) cerebral vascular iNOS staining was almost
exclusively restricted to vessels that showed evidence of
inflammatory activation including deposition of intravas-
cular fibrin. In samples obtained from the Sydney Brain
Bank none showed more than trace amounts of iNOS
staining (example shown in Fig. 3E). The low level of
iNOS staining of the frontal lobe of the Malawi control
with the fatal gut haemorrhage is illustrated in Fig. 3F.Page 6 of 17
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MIF staining of blood vessels of control, cerebral malaria and sepsis brains and chest wall. A. Brain and B. chest 
wall of Caucasian adult controls, C brain and D chest wall of African paediatric control, E Brain and F chest wall of cerebral 
malaria case, and G brain and H chest wall of sepsis case (Streptococcus pneumoniae ). Scale bar, 100µm.Page 7 of 17
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In contrast to MIF, iNOS was even across the cytoplasm,
and not present in nuclei of any cells. As shown in Table
1, most of the cases of clinically diagnosed cerebral malar-
ia in Category A showed low levels of iNOS in chest wall
small blood vessels and skeletal muscle myofibrils (Fig.
4A). The remainder of category A and the 7 cases in Cate-
gory B had high levels of iNOS staining in chest wall small
blood vessels (Fig. 4B) and skeletal muscle (Fig. 4C), but
cases in which this was observed did not include the few
in these groups with significant brain vessel iNOS. Most of
the 14 cases in Category C had high levels of iNOS in ves-
sel walls (Fig. 4D) and skeletal muscle (Fig. 3E) of the
chest wall, although a few stained weakly (Table 1). There
was no apparent association between the presence or in-
tensity of iNOS staining in muscle and that in brain in any
of the groups. Where iNOS was appreciable in cerebral
vessels (eg Fig. 3C) it was never as strong as that seen in
vessels in chest walls (eg Fig. 4D) and elsewhere (not
shown). Parasites (whether sequestered or not) or pig-
ment were rare to absent, even in those chest wall sections
that stained heaviest for iNOS. Both Malawi coma con-
trols (Figs 4F and 4G), and the Canberra controls (exam-
ple in Fig. 4H) had no detectable iNOS in vessels or
skeletal muscle of chest wall sections.
Figure 2
MIF staining in chest wall skeletal muscle. A. Caucasian adult control, B. African paediatric control, C. cerebral malaria 
case, and D. sepsis case (Haemophilus influenzae). Scale bar, 100 µm.Page 8 of 17
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iNOS staining in cerebral malaria brains and in control brains. A: Category A cerebral malaria (no discernible histo-
logical changes except the occasional rare malarial pigment within vessels) frontal lobe showing negligible vascular wall iNOS. 
B: Category B (no discernible changes except significant sequestration of parasitised erythrocytes) occipital region showing 
negligible vascular wall iNOS. C: Category C (microhemorrhages, significant mononuclear cell accumulations, and also seques-
tered parasites) frontal lobe showing notably more vascular wall iNOS than seen in categories A or B. D: Mononuclear cells in 
Category C frontal lobe staining in parallel with the vessel walls for iNOS. E: iNOS immunostaining in mid-brain of Caucasian 
control brain. F: iNOS immunostaining in pons region of a childhood Malawi control brain. Scale bar, 100 µm.Page 9 of 17
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iNOS staining in chest wall in cerebral malaria and in controls. A: Category A cerebral malaria chest wall and skeletal 
muscle both showing negligible vascular wall iNOS. B: Category B cerebral malaria chest wall showing high vascular wall iNOS, 
and, in C, skeletal muscle. D: Category C cerebral malaria chest wall showing high vascular wall iNOS and, in E, skeletal mus-
cle. F and G: Negligible iNOS in chest wall blood vessel walls and skeletal muscle in two Malawi childhood controls, and in H, 
same in Caucasian control. Scale bar, 100 µm.Page 10 of 17
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iNOS staining in brain blood vessels
A further 10 comatose children had very few (3) or no de-
tectable (7) malaria parasites in thick smears and had a
clinical diagnosis other than malaria to account for their
disease. Two of these 10 patients had bacterial meningitis
(one each culture positive for H. influenzae and S. pneumo-
niae), two had a positive blood culture (one S. enteritidis,
one E. coli) and one, with a lymphocytic infiltrate in the
cerebrospinal fluid, was diagnosed histologically, includ-
ing the presence of acid-fast organisms, as tuberculous
meningitis. The causes of death of the other 5 were
judged, on clinical grounds, to be organophosphate poi-
soning (1), salicylate overdose (1) (both with low grade
parasitaemia), hyponatraemia in a child with severe brain
damage from previous bacterial meningitis (with tran-
sient low-grade parasitaemia), and hypoglycaemia of un-
known cause (2) (both aparasitaemic). As available,
sections from 3 to 13 areas from the brain regions listed
earlier, (always including cerebrum, mid-brain or pons),
Figure 5
iNOS staining in brain and chest wall from culture-defined cases of septis. Pattern shown was the same in all cases 
illustrated. A: Frontal lobe of brain from Streptococcus pneumoniae infection, showing negligible vascular wall iNOS. B: Meninges 
from pons region from Salmonella enteriditis infection, with strong iNOS staining. C: Chest wall vessel and muscle from E coli 
infection showing strong staining for iNOS. D: Chest wall vessel and muscle from Haemophilus influenzae infection showing 
strong staining for iNOS. Scale bar, 100 µm.Page 11 of 17
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cluding those from all the bacterially defined cases of sep-
tic meningitis, scored 0-1+ for iNOS (Fig. 5A; Table 1).
iNOS staining of these vessels was significantly less likely
to score 3+ or 4+ than in cerebral vessels in Category C cer-
ebral malaria (p = 0.005), but was not different from that
seen in Categories A or B (each p = 1.0), or the cerebral
malaria group as a whole (p = 0.066). Meningeal vessel
walls from the septic meningitis cases stained conspicu-
ously more strongly for iNOS than did vessel walls within
the brain (Fig. 5B).
iNOS staining in blood vessels and skeletal muscle in chest wall
Staining for iNOS in blood vessels (p = 0.730) and skele-
tal muscle (p = 0.282) was not significantly different, in
degree, from that seen in these locations in the 32 cerebral
malaria cases (Table 1). In all groups except the controls
there were patients with intense muscle iNOS staining
who had little or no iNOS evident in the cerebral vascula-
ture walls. Examples of chest wall microvessel and myofi-
bril iNOS staining in patients with non-malarial coma
and bacteraemia are shown in Figs 5C and 5D.
When MIF and iNOS expression in chest blood vessel
walls were compared, those in 16 samples stained
strongly (3+ or 4+) for both MIF and iNOS, and 12
showed strong (3+ or 4+) MIF plus low (0-1+ or 2+) stain-
ing iNOS, 11 showed low (0-1+ or 2+) staining for both
MIF and iNOS, and only 4 had low MIF and high iNOS.
Thus, of the 20 with high iNOS, only four had low MIF,
whereas 11 of the 22 with low iNOS had low MIF. The val-
ue of Cohen's kappa as a measure of agreement in the MIF
and iNOS classifications was 0.25 with a standard error of
0.085. Using a Normal approximation, this is significantly
different from zero at the 0.1% level. The G2 for lack of
symmetry was 18.08, which is significant at the 1% level
in relation to the chi-squared distribution with six degrees
of freedom, showing a strong tendency for the MIF score
to be greater than the iNOS score.
Discussion
Attempts to explain the pathogenesis of severe falciparum
malaria have, in recent years, been dominated by two ap-
proaches now generally considered complementary: poor
tissue oxygen supply due to the obstructive effects of mi-
crovascular sequestration [35] and the local and systemic
effects of the excessive release of the cytokines that regu-
late cell-mediated immunity [36]. In this study we inves-
tigated these interactions further, through
immunohistochemical staining for MIF and iNOS in
brain and other tissues from paediatric autopsies in
Malawi. iNOS protein expression in the brain in fatal ma-
laria has been reported in one previous study, of adults in
south-east Asia [37]. Sampling the cerebrum only, these
authors reported immunohistochemical staining for
iNOS in a range of cell types, most strongly in endothelial
cells, in 13 cases of adult cerebral malaria. Bacterial septi-
cemia cases were not studied. Judging from the universal
presence of microhemorrhages reported in all brains ex-
amined, these adult brains correspond closest to the Cat-
egory C subgroup of our paediatric cerebral malaria cases.
Tissues from systemic human disease have not previously
been examined for MIF. The normal presence of MIF pro-
tein in bronchial epithelial cells, epidermis and subcuta-
neous glandular structures, as we have found in these
human tissues, has previously been reported, by this same
technique, in the rat [38]. It has not previously been re-
ported in skeletal muscle. A function of MIF possibly rele-
vant to the pathology of severe malaria and sepsis, and
consistent with its presence in skeletal muscle, is its ability
to increase synthesis of fructose 2,6-bisphosphate
(F2,6BP), a positive allosteric regulator of glycolysis [39].
A neutralising anti-MIF mAb prevents the hypoglycaemia
and increased muscle F2,6BP levels caused in mice by TNF
[39]. In African children with severe malaria, hypoglycae-
mia is associated with very high circulating concentrations
of TNF [4]. These observations are consistent with a role
for MIF in the pathogenesis of malarial hypoglycaemia
through the excessive enhancement of glycolysis in skele-
tal muscle. The presence of MIF in skeletal muscle would,
by inhibiting the suppressive effects of glucocorticoids on
inflammatory cytokine production [19], allow the ob-
served high iNOS induction (Fig. 4C).
MIF protein has previously been reported in ependymal
cells, astrocytes, and subpopulations of neurons in the bo-
vine brain [40], but no comment was made on its pres-
ence or absence in cerebral blood vessel walls. These
authors also noted its intranuclear location in several cell
types, as we have in skeletal muscle, ependymal cells, and
non-cerebral endothelial cells in malaria and sepsis. Nu-
clear staining of skeletal muscle for MIF was commonly
associated with high iNOS in the cytoplasm of these cells.
The roles of MIF in nuclei have not yet been determined,
the only functional association of its expression in this or-
ganelle so far reported being in pulmonary adenocarcino-
ma cells, where is it is associated with a better clinical
outcome [41]. As noted, MIF had an asymmetrical associ-
ation with iNOS in chest vessel walls. This is consistent
with MIF appearing before iNOS, as this literature
predicts.
MIF protein has been reported in the endothelial cells of
human umbilical vein [22], but to our knowledge neither
the neuropil nor blood vessels of human brains have pre-
viously, except for our recent conference proceedings re-
port [42], been examined for its presence. The absence of
MIF staining in the walls of the cerebral vasculature during
malaria and bacterial sepsis (Figs 3F &3H), despite evi-Page 12 of 17
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is remarkable. It was also absent in all other brains exam-
ined, including an additional 17 from other children dy-
ing of various causes in Malawi (data not shown). This
absence could help explain previous observations of oth-
ers. For example, the brain could thereby be innately pro-
tected from the excesses of systemic inflammation, in the
same way as neutralising anti-MIF antibody protects the
whole organism in experimental sepsis [16]. Absence of
local vascular wall MIF would mean that glucocorticoids
would be locally unopposed, leading to much less local
transcription of inflammatory responses in the brain than
elsewhere in the body, as reported in DNA microarray
studies of the caecal ligation and puncture model of sepsis
[43], another example of systemic inflammation. This is
consistent with cerebral vasculature iNOS never, in our ex-
perience, achieving densities seen in peripheral vessels
(Figs 3C vs 4D).
We suggest two possible reasons why low MIF, and thus,
through unrestricted glucocorticoid activity, relatively low
iNOS, should be biologically advantageous in the cerebral
vasculature. First, since normal brain function requires a
subtly triggered network of calcium-controlled generation
of NO from constitutive NOS, relatively uncontrolled re-
lease of NO through iNOS could override this, with loss
of function. Second, we propose that dangerous increases
in brain perfusion pressure are minimised through MIF
being absent from the cerebral vasculature. The brain is
protected from capillary rupture because resistance of
larger cerebral arteries is remarkably high, keeping the
pressure in intracranial arterioles lower than in similar
vessels elsewhere [44]. Endotoxin-induced iNOS dimin-
ishes the normal constrictor responses that maintain the
normally low cerebral perfusion pressure [45]. Were cere-
bral vascular iNOS to increase as much during a severe
systemic infection as elsewhere in the body, the resistance
of cerebral arterioles would decrease accordingly, and the
hydrostatic pressure of cerebral capillaries would increase,
exposing these vessels to pressure they normally do not
experience and cannot withstand, and microhemorrhages
would ensue. This could account for the co-localisation of
vascular wall iNOS and microhemorrhages in Category C
brains. An inability to induce MIF in the cerebral vascula-
ture, leading in turn to less induction of iNOS, may thus
have a survival advantage in preventing excessive increases
in cerebral perfusion pressure, and the risk of intracranial
haemorrhage during systemic infections. This may also
explain the observation that endotoxin infusion into hu-
man volunteers reduces systemic vascular resistance, but
leaves cerebral vascular resistance unaltered [46].
Since MIF opposes the function of glucocorticoids, and is
thus able to upregulate iNOS [47,48], it was of interest to
document the change in iNOS as well as MIF in fatal hu-
man malaria and sepsis. Except for its routine presence in
human airway epithelium [49], iNOS is rarely detectable
by immunological methods in healthy tissues. For exam-
ple iNOS has been reported to be absent by immunohis-
tochemistry in normal human blood vessel wall [50] and
by reverse transcriptase-driven in situ polymerase chain re-
action none could be detected in human brain [51,52],
and very little in cerebellum or skeletal muscle [53]. Most
of these authors have used the main commercial antibody
source, Transduction Laboratories, that we have em-
ployed. Our argument that we are indeed detecting
authentic iNOS is strengthened by detecting the same an-
tigen distribution with three unrelated anti-iNOS anti-
bodies described in Methods.
A third (11/32) of the Malawian children diagnosed as
cerebral malaria on the basis of established clinical crite-
ria, including peripheral P falciparum parasitaemia, had
neither histological changes, nor more than scant seques-
tered parasites, in the brain sections we stained for iNOS
(Category A in the Table 1). The relative absence of para-
sites from these tissue sections, even though they were
prominent on peripheral blood smears on admission,
cannot be explained by their clearance from the brain by
antimalarial treatment, since very similar average times
(mean +/- SEM 21.2 +/- 4.6 hr for Category A, and 27.0 +/
- 6.0 hr for Category B) had lapsed from admission, when
blood smears were taken and treatment began, to time of
death in both these cases and those in Category B, in
which parasites were common in brain sections. In the
majority of cases in Category A, iNOS was scanty or unde-
tectable in brain vessels (Fig. 3A). In each patient group
there was evident diversity in the quantity of iNOS detect-
able in both brain and muscle (Table 1). As discussed, MIF
differences could contribute to this. Since the local release
of infected red cell contents during post-schizogony rup-
ture of erythrocytes is accepted to trigger the inflammatory
cascade in malaria, the intensity of staining for iNOS
would vary throughout the 48 hr schizogony cycle. Since
the tissue sections were collected at variable times during
the cycle, some variation in iNOS staining intensity be-
tween patients with otherwise similar clinical syndromes
is therefore inevitable.
About half of the cerebral malaria cases (Category C, 14/
32) showed significant microhemorrhages, intravascular
accumulations of mononuclear cells, and at times fibrin.
Mononuclear cell accumulations (Fig. 2H) have been de-
scribed previously in cerebral malaria brains from Indian
adults [54] and Thai adults [55,56], but not, so far as we
are aware, African children. These features were negligible
in the brain sections examined from the other cerebral
malaria categories. In contrast to the low iNOS seen in cer-
ebral vessel walls in Categories A and B, all except three of
the 14 brains in Category C scored 3+ or 4+. It is possiblePage 13 of 17
(page number not for citation purposes)
Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/6that mononuclear cells, fibrin and parasitised red cells
could all have contributed to local ischaemia by reducing
blood flow through affected vessels, and the consequent
ischaemia could, in turn, have contributed to iNOS in-
crease [57]. However, in view of the negligible iNOS in-
duction in Category B brains, despite intense
sequestration, it seems more likely that the iNOS induc-
tion in vascular walls uniquely observed in Category C
brains has resulted from the strong local stimulus provid-
ed by recent rupture of schizont-infected red cells. Never-
theless, histological staining cannot establish a chain of
cause and effect; this awaits other types of
experimentation.
High iNOS concentrations in cerebral vessel walls in Cat-
egory C was almost invariably associated with equally
strong, and often stronger, staining in chest wall vascula-
ture and skeletal muscle (and elsewhere; unpublished da-
ta). The virtual absence of sequestered parasites in chest
wall sections with intense iNOS staining (Figs 2D and 2E)
suggests that a circulating iNOS inducer, such as TNF, may
be responsible. The intense iNOS staining in striated mus-
cle from Category B patients who had extensive brain se-
questration but no or little iNOS, may similarly indicate a
circulating stimulus to muscle iNOS in severe malaria in
the absence of a local stimulus in the brain. This stimulus
could have systemic metabolic consequences that
contribute to altered consciousness through mechanisms
other than the local cerebral events observed histological-
ly in Category C cases. Our data thus support the observa-
tion that the syndrome diagnosed clinically as cerebral
malaria may be the result of a variety of different underly-
ing events [58], some being local within the brain, and
others a metabolic disorder resulting from the systemic in-
fection [59].
The intense staining for iNOS in cerebral vessel walls that
characterise Category C brains could have local patholog-
ical consequences. NO generated by the constitutive
forms of NOS performs many essential signalling and reg-
ulatory roles in the brain, and these normally are precisely
controlled by cytoplasmic calcium levels. Examples in-
clude the regulation of cerebral blood flow [60], N-me-
thyl-D-aspartate (NMDA) receptors [61], and the
induction of sleep when release occurs in the pedunculo-
pontine tegmentum [62]. NO also inhibits the Na+/K+ AT-
Pase-driven pump [63,64] that prevents sodium and
therefore water accumulation, or oedema, in various tis-
sues, including brain. These neuronal homeostatic func-
tions of NO can be expected to be altered when iNOS is
induced in the brain in high concentrations, as we de-
scribe in some of these cases. For example, it has been
proposed that the reduced uptake of glutamate by astro-
cytes when inflammatory cytokine levels are high, allow-
ing this excitotoxin to build up to levels that can cause
seizures, is mediated by the NO that these cytokines in-
duce [65]. In addition, vasodilation from the NO so gen-
erated could, from animal studies [45], lower the high
cerebral vascular resistance that normally protects the cer-
ebral capillaries from rupture [44].
Levels of nitrogen oxides, indirect measures of total NO
production, in plasma [66,67], urine or cerebrospinal flu-
id [68] have not been associated with degree of coma in
severe falciparum malaria. However, total circulating ni-
trite plus nitrate merely gives an indication of total NO
production in the whole body, and is too blunt an instru-
ment to measure the local concentration of a molecule
that acts within a cell or two of its site of production. The
total NO production in the body's large mass of skeletal
muscle, as implied by the degree of iNOS induction in
muscles we have observed, could be sufficient to obscure
the contribution to plasma levels by the cerebral vascula-
ture. Likewise, our arguments for pathogenic roles for
iNOS-induced NO in severe falciparum malaria do not
conflict with studies on an iNOS promoter polymorphism
associated with increased NO production and protection
from severe malaria in East African children [69], since a
population study gives no evidence against these mole-
cules being deleterious in individual fatal cases. In an ad-
ditional study to that reported here we have found
nitrotyrosine where iNOS is detectable, suggesting that
NO is actually generated by this enzyme.
Non-malarial illnesses
A group of 10 comatose children were found, after admis-
sion into the study, to be carrying only few or no malaria
parasites (and thus were not diagnosed as cerebral malar-
ia), and pathogenic bacteria were cultured from the blood
of 5 of them (Table 1). As noted, their cerebral vascular
walls contained little iNOS, although iNOS was evident in
skeletal muscle and the walls of blood vessels within it. In
Category A cerebral malaria cases, the brain vessels were
similarly devoid of parasites or iNOS staining. These pa-
tients also suffered a fatal comatose illness, suggesting that
cerebral vascular wall NO is not necessary for encephalop-
athy to develop in systemic infections. The high iNOS in
the chest wall vessels and skeletal muscle of some of the
culture-positive sepsis cases (Figs 3C and 3D), as well as
our Category A cerebral malaria cases (Figs 2B,2C,2D,2E),
suggests that death may have been due to systemic inflam-
mation rather than intracerebral mechanisms. It is also
consistent with the high nitrite/nitrate levels recently
reported in skeletal muscle of fatal, but not non-fatal, sep-
sis cases [70].
The considerable induction of iNOS in skeletal muscle in
a number of our malaria and sepsis patients is consistent
with parallels in their pathophysiology [71]. Lanone and
co-workers [72] recently made the first report of iNOS inPage 14 of 17
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findings (Fig. 3D), and extend it to falciparum malaria
(Fig. 2E). From the recognised effects of iNOS-induced
NO in skeletal muscle and diaphragm [73], such NO
could cause poor contractility of the ventilatory muscles,
and thus contribute to the terminal respiratory arrest ob-
served in severe falciparum malaria by others in African
children [74]. Because of a need to hyperventilate to com-
pensate for metabolic acidosis, a common condition in
severe malaria in Malawian children [75], their respiratory
muscles would be particularly vulnerable to the effect of
this iNOS.
Conclusions
We have demonstrated iNOS in the walls of microvessels
in the brain and in skeletal muscle in children with fatal
malarial and bacterial infections, and observed considera-
ble diversity in the intensity of this phenomenon, iNOS
being particularly associated with other features of intra-
vascular inflammation in the brain, but not in muscle.
MIF has been detected in a pattern that is compatible with
this, and also offers fresh insights into differences between
the brain and elsewhere. An autopsy-based study of this
kind cannot demonstrate that iNOS-generated NO plays a
role in the pathogenesis of disease or death in fatal malar-
ia [26], but it moves towards that conclusion, broadening
the range of tissues involved. These results also agree with
the view that cerebral malaria in African children is a col-
lection of overlapping syndromes acting through different
organ systems, with several mechanisms potentially com-
bining to cause coma and death.
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